Truncating Titin (TTN) Variants in Chemotherapy-Induced Cardiomyopathy

被引:58
作者
Linschoten, M. [1 ]
Teske, A. I. [1 ]
Baas, A. F. [2 ]
Vink, A. [3 ]
Dooijes, D. [2 ]
Baars, H. F. [4 ]
Asselbergs, F. W. [1 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Room E03-511,POB 85500, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[4] Elisabeth TweeSteden Ziekenhuis, Dept Cardiol, Tilburg, Netherlands
[5] Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands
[6] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England
[7] UCL, Farr Inst Hlth Informat Res, London, England
[8] UCL, Inst Hlth Informat, London, England
关键词
Cardiotoxicity; chemotherapy; heart failure; genetics; CARDIOTOXICITY;
D O I
10.1016/j.cardfail.2017.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemotherapy-induced cardiomyopathy (CCMP) is a complication of chemotherapy treatment occurring in 9% of patients treated with the use of anthracyclines. Currently, risk stratification is based on clinical risk factors that do not adequately account for variable individual susceptibility. This suggests the presence of other determinants. In this case series, we describe 2 women with breast cancer who developed severe heart failure within months after chemotherapy. Genetic screening revealed truncating frameshift mutations in TTN, encoding the myofilament titin, in both women. To our knowledge, this is the 1st report of an association between truncating ITN variants and CCMP. Because truncations in TTN are the most common cause of familial and sporadic dilated cardiomyopathy, further research is needed to establish their prevalence in patients presenting with CCMP.
引用
收藏
页码:476 / 479
页数:4
相关论文
共 50 条
[21]   Titin-Truncating Variants Predispose to Dilated Cardiomyopathy in Patients Genetically Similar to African Reference Populations [J].
Depaolo, John ;
Bornstein, Marc ;
Judy, Renae ;
Levin, Michael ;
Arany, Zoltan ;
Damrauer, Scott M. .
CIRCULATION, 2023, 148
[22]   Efficacy and safety of cardiac resynchronization therapy in chemotherapy-induced cardiomyopathy: A systematic review [J].
Shehram, Muhammad ;
Khalid, Hiba ;
Shafique, Hafiz Muhammad ;
Umer, Bakht ;
Zafar, Awais ;
Ullah, Asif ;
Zaidi, Syed Muhammad Jawad ;
Basit, Jawad ;
Mehmoodi, Amin ;
Malik, Jahanzeb .
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2023, 28 (05)
[23]   Transplantation for chemotherapy-induced cardiomyopathy-case series and review of current practice [J].
Balakrishnan, Komarakshi Rajagopalan ;
Rao, Kemundel Genny Suresh ;
Subramaniam, Ganapathy ;
Sharma, Dhruva .
INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 36 (SUPPL 2) :287-293
[24]   Sitting ECGs to diagnose chemotherapy-induced cardiomyopathy/heart failure [J].
Madias, John E. .
JOURNAL OF ELECTROCARDIOLOGY, 2023, 81 :167-168
[25]   Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy [J].
Lalario, Andrea ;
Del Mestre, Eva ;
Lo Casto, Michele ;
Nuzzi, Vincenzo ;
Manca, Paolo ;
Bromage, Daniel, I ;
Barbati, Giulia ;
Merlo, Marco ;
Sinagra, Gianfranco ;
Cannata, Antonio .
ESC HEART FAILURE, 2022, 9 (05) :3052-3059
[26]   Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathy [J].
Ezzeddine, Fatima M. ;
Saliba, Antoine N. ;
Jain, Vaibhav ;
Villarraga, Hector R. ;
Herrmann, Joerg ;
Asirvatham, Samuel J. ;
Cha, Yong-Mei .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (04) :625-632
[27]   Titin truncating mutations: A rare cause of dilated cardiomyopathy in the young [J].
Fatkin, Diane ;
Lam, Lien ;
Herman, Daniel S. ;
Benson, Craig C. ;
Felkin, Leanne E. ;
Barton, Paul J. R. ;
Walsh, Roddy ;
Candan, Sukru ;
Ware, James S. ;
Roberts, Angharad M. ;
Chung, Wendy K. ;
Smoot, Leslie ;
Bornaun, Helen ;
Keogh, Anne M. ;
Macdonald, Peter S. ;
Hayward, Christopher S. ;
Seidman, J. G. ;
Roberts, Amy E. ;
Cook, Stuart A. ;
Seidman, Christine E. .
PROGRESS IN PEDIATRIC CARDIOLOGY, 2016, 40 :41-45
[28]   Rare Titin (TTN) Variants in Diseases Associated with Sudden Cardiac Death [J].
Campuzano, Oscar ;
Sanchez-Molero, Olallo ;
Mademont-Soler, Irene ;
Riuro, Helena ;
Allegue, Catarina ;
Coll, Monica ;
Perez-Serra, Alexandra ;
Mates, Jesus ;
Pico, Ferran ;
Iglesias, Anna ;
Brugada, Ramon .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10) :25773-25787
[29]   Chemotherapy-induced cardiotoxicity: importance of early detection [J].
Cardinale, Daniela ;
Cipolla, Carlo Maria .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (12) :1297-1299
[30]   Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity [J].
Storozynsky, Eugene .
FUTURE CARDIOLOGY, 2015, 11 (04) :421-424